Dunzendorfer 1983.
Methods | Randomized, parallel, double‐blind, placebo‐ controlled study. | |
Participants | N=30; Geographic region: Germany Mean age: 39 Discontinuations/Not available to follow‐up: none reported | |
Interventions | Study duration: Phenoxybenzamine (Dibenzyran) 10 mg (n=17) twice daily vs. placebo (n=13). Study duration: 12 weeks | |
Outcomes | Symptomatic changes (pain evaluation); Erythrocyte and leukocyte counts in the urine following prostate palpation; adverse events. | |
Notes | Block randomization | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment (selection bias) | Unclear risk | B ‐ Unclear |